These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6326685)

  • 1. [Clinical trial on the effect of tegafur (SF-SP)].
    Futatsuki K; Shimada S; Kanda Y; Ishibashi I; Sendai H; Akazawa S; Hattori M
    Gan To Kagaku Ryoho; 1984 May; 11(5):1112-5. PubMed ID: 6326685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of tegafur encapsulated with slow-releasing granules (SF-SP) for patients with cancer of the digestive organs].
    Kameda C; Tanaka T; Shiomi M; Saka M; Katsu K; Itoh S
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2526-30. PubMed ID: 6439120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cooperative phase II study of releasing tegafur (SF-SP) against advanced digestive cancers].
    Ibayashi J
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1414-9. PubMed ID: 6430244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phase II study of sustained released granules of tegafur (SF-SP) on inoperable or recurrent gastric cancer].
    Sakata Y; Yoshida Y
    Gan To Kagaku Ryoho; 1985 May; 12(5):1068-72. PubMed ID: 3922308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Joint clinical Phase II study of SF-SP].
    Sato T; Sato H; Hanatani Y
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1210-7. PubMed ID: 6428321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cooperative phase II study of spansule tegafur (SF-SP)].
    Taguchi T
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):319-26. PubMed ID: 6421250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The case studies on oral administration of tegafur encapsulated with slow releasing granule (SF-SP) for three rectal patients].
    Sato T; Sekine S; Katsumi S; Mukae S; Watanabe S; Furukawa R; Watanabe I; Endo S
    Gan To Kagaku Ryoho; 1984 May; 11(5):1107-11. PubMed ID: 6426404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study on two different types of tegafur for recurrent breast cancer].
    Taguchi T
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):312-8. PubMed ID: 6421249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative clinical study of SF-SP therapy and SF-SP plus BH-AC therapy in gastrointestinal cancer. Tokyo Cancer Chemotherapy Cooperative Study Group].
    Izumi T; Yoshida M; Kamaro T; Sato H
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3215-20. PubMed ID: 3096218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination chemotherapy of UFT with adriamycin in advanced gastrointestinal cancer].
    Koda K; Kure T; Terada S; Arai R; Morita K; Hirayama M; Terui T; Fukushi A; Yoshizaki N; Nakazawa O
    Gan No Rinsho; 1987 Sep; 33(11):1329-35. PubMed ID: 3118075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
    Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of chemotherapy in the field of internal medicine--clinical experience with SF-SP].
    Irie K; Yasutake K; Imamura Y; Yoshimura Y; Nakamura T; Yoshida M; Fujisawa T; Nishimura S; Mizogami H; Sawada Y
    Gan To Kagaku Ryoho; 1986 May; 13(5):1893-6. PubMed ID: 3085595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I evaluation of oral tegafur.
    Bedikian AY; Bodey GP; Valdivieso M; Burgess MA
    Cancer Treat Rep; 1983 Jan; 67(1):81-4. PubMed ID: 6413058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A phase II study of ranomustine (MCNU) tablets in patients with gastrointestinal cancer--by cooperative study group].
    Taguchi T
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2420-6. PubMed ID: 6497400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
    Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
    Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
    Woo IS; Moon DH; Shim BY; Lee MA; Byun JH; Kim KW; Kang JH; Choi MG; Chung IS; Hong YS; Park SY; Lee KS
    Jpn J Clin Oncol; 2005 Jan; 35(1):13-7. PubMed ID: 15681598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Two elderly patients with advanced gastric cancer responding to chronomodulation chemotherapy with tegafur + cisplatin + isovorin followed by oral administration of S-1].
    Kobayashi A; Yamaguchi M
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):1003-7. PubMed ID: 11478129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sequential changes in blood concentrations of tegafur and 5-FU during oral administration of fine granules of tegafur in patients with primary liver cancer].
    Onji M; Yamashita Y; Horiike N; Kanaoka M; Ohta Y; Yoshida T; Hattori M
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):480-8. PubMed ID: 6307183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics and a phase I study of tegafur-uracil enterogranules in cancer patients].
    Kamiya O; Hoshino A; Ohara K; Nagata K; Kojima T; Sugihara T; Yamada M; Suzuki M; Kimura K; Fujii S
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2565-72. PubMed ID: 6418079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic study of tegafur in the hepatic tissue obtained from the patients with liver cancer].
    Tomita M; Ishikawa H; Hirano T; Nakagoe T; Shimizu T; Kusano H; Ifuku M
    Gan To Kagaku Ryoho; 1992 May; 19(5):671-6. PubMed ID: 1580640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.